Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Deciphering Staar Surgical (STAA) International Revenue Trends
Review Staar Surgical's (STAA) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Zacks
More News
Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now
Cooper Companies' premium lens migration, MiSight growth and fertility recovery offer long-term upside despite Asia-Pacific, tariff and FX pressures.
Zacks
Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of +47.62% and +3.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
STAAR Surgical Reports Second Quarter 2026 Results
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today reported results for the second quarter ended July 3, 2026. Second Quarter 2026 Financial Overview Net sales of $93.5 million, up 111...
Business Wire
Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of +2.87% and +1.81%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Staar Surgical (STAA) Upgraded to Strong Buy: What Does It Mean for the Stock?
Staar Surgical (STAA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that following an extensive global search, its Board of Directors (the "Board") has appointed Warren...
Business Wire
STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on...
Business Wire
Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of +23.96% and +3.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced strong preliminary net sales for the second quarter ended July 3, 2026. STAAR is announcing its preliminary net sales in...
Business Wire

Advertisement|Remove ads.